Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol

Despite standard of care with maximal safe resection and chemoradiation, glioblastoma is the most common and aggressive type of primary brain cancer. Surgical resection provides a window of opportunity to locally treat gliomas while the patient is recovering, and before initiating concomitant chemor...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurosurgery practice 2023-12, Vol.4 (4)
Hauptverfasser:	Ramos-Fresnedo, Andres, Al-Kharboosh, Rawan, Twohy, Erin L, Basil, Aleeshba N, Szymkiewicz, Ewa C, Zubair, Abba C, Trifiletti, Daniel M, Durand, Nisha, Dickson, Dennis W, Middlebrooks, Erik H, Abarbanel, David N, Tzeng, Stephany Y, Almeida, Joao Paulo, Chaichana, Kaisorn L, Green, Jordan J, Sherman, Wendy J, Quiñones-Hinojosa, Alfredo
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!